Cargando…

Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata

Detalles Bibliográficos
Autores principales:	Blume-Peytavi, Ulrike, Vogt, Annika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486199/ https://www.ncbi.nlm.nih.gov/pubmed/26137570 http://dx.doi.org/10.1016/j.ebiom.2015.03.022

Ejemplares similares

A Comment on JAK Inhibitors for Treatment of Alopecia Areata
por: Trüeb, Ralph Michel, et al.
Publicado: (2018)

Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018)

Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023)

Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis
por: Liu, Ming, et al.
Publicado: (2023)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
por: Yale, Katerina, et al.
Publicado: (2020)

Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
por: Rachubinski, Angela L., et al.
Publicado: (2019)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Identity and psychological distress in alopecia areata
por: Hunt, Nigel
Publicado: (2022)

Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
por: SEDEH, Farnam Barati, et al.
Publicado: (2023)

A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
por: Dillon, Kerry-Ann L
Publicado: (2021)

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
por: Jabbari, Ali, et al.
Publicado: (2015)

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Addressing the psychosocial burden of alopecia areata in clinical practice
por: Hirani, Rahim, et al.
Publicado: (2022)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway
por: Sardana, Kabir, et al.
Publicado: (2023)

The Changing Landscape of Alopecia Areata: The Translational Landscape
por: Wang, Etienne C. E., et al.
Publicado: (2017)

Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
por: Wei, Dongfan, et al.
Publicado: (2023)

Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2021)

Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients
por: Shivanna, Chandrashekar Byalekere, et al.
Publicado: (2018)

Alopecia Areata
Publicado: (1908)

Alopecia Areata
por: Reid, Thomas
Publicado: (1869)

Alopecia Areata
por: Spangenthal, Joseph
Publicado: (1898)

Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
por: Mattsson, Johan, et al.
Publicado: (2023)

9th Skin Academy Symposium: Building Bridges in Dermatology Chair’s Introduction
por: Blume-Peytavi, Ulrike
Publicado: (2017)

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
por: Yan, Diqin, et al.
Publicado: (2022)

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
por: Kołcz, Kinga, et al.
Publicado: (2023)

Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2022)

Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries
por: Vañó-Galván, Sergio, et al.
Publicado: (2023)

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
por: Langley, Paul C
Publicado: (2020)

Management of alopecia areata
por: Harries, M J, et al.
Publicado: (2010)

Alopecia areata incognita
por: Molina, Luciana, et al.
Publicado: (2011)

IS ALOPECIA AREATA PSYCHOSOMATIC ?
por: Devar, J.V.
Publicado: (1983)

Linear Alopecia Areata
por: Shetty, Shricharith, et al.
Publicado: (2016)

Ringworm and Alopecia Areata
Publicado: (1898)

The Etiology of Alopecia Areata
Publicado: (1904)

Linear alopecia areata
por: Yu, Lijuan, et al.
Publicado: (2018)

The Fungus of Alopecia Areata
Publicado: (1874)

Immunology of alopecia areata
por: ŻEBERKIEWICZ, MARTA, et al.
Publicado: (2020)

The Naming of Alopecia Areata
por: Montgomery, Douglass W.
Publicado: (1931)

Immunopathogenesis of alopecia areata
por: Olayinka, Jadesola (Jadé) Temitope, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_88jon9p3qhp1khb0iulc2pbm2c